antithrombomodulin antibody Search Results


anti-thrombomodulin antibody  (TargetMol)
N/A
   Buy from Supplier
cd141  (Boster Bio)
92
Boster Bio cd141
Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and <t>CD141+</t> cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.
Cd141, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antithrombomodulin+antibody/pm36780882-62-45-50?v=Boster+Bio
Average 92 stars, based on 1 article reviews
cd141 - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
anti-thrombomodulin/thbd antibody picoband  (Boster Bio)
N/A
Boster Bio Anti-Thrombomodulin/THBD Antibody Picoband® catalog # A01325-3. Tested in ELISA, Flow Cytometry, IP, IF, IHC, ICC, WB applications. This antibody reacts with Human, Rat. The brand Picoband indicates this is a premium antibody that
   Buy from Supplier
anti-thrombomodulin polyclonal antibody  (TargetMol)
N/A
   Buy from Supplier
anti-thrombomodulin thbd antibody  (Boster Bio)
N/A
Boster Bio Anti-Thrombomodulin THBD Antibody catalog # A01325-2. Tested in WB,IHC,IP applications. This antibody reacts with Human.
   Buy from Supplier
anti-thrombomodulin polyclonal antibody 2  (TargetMol)
N/A
   Buy from Supplier
anti thrombomodulin cd141 antibody  (Abcepta)
N/A
   Buy from Supplier
anti-thrombomodulin / cd141 (endothelial cell marker) monoclonal antibody  (Boster Bio)
N/A
Boster Bio Anti-Thrombomodulin / CD141 (Endothelial Cell Marker) Monoclonal Antibody (Catalog # M01325). Tested in ELISA, IHC applications. This antibody reacts with Human.
   Buy from Supplier

Image Search Results


Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.

Journal: Neuroimmunomodulation

Article Title: Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features.

doi: 10.1159/000529626

Figure Lengend Snippet: Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.

Article Snippet: The section was incubated with 10% normal goat serum in phosphate-buffered saline at room temperature, followed by incubation with the primary antibody against CD303 (rabbit antihuman CD303, D161051-0100, Sango Biotech, Shanghai, China), CD1c (mouse anti-human CD1c, TA505384, Zhongshan Jinqiao Biotechnology Co., Ltd, Beijing, China), and CD141 (Rabbit antihuman CD141, BM4158, Boster Biological Technology, Wuhan, China).

Techniques: Comparison

Fig. 5. Comparison of circulating dendritic cell subsets in patients with different MGFA (Myasthenia Gravis Foundation of America) classification as shown, there were no differences in the frequencies of pDCs (a), CD1c+ cDCs (b), and CD141+ cDCs (c) in patients with different MGFA classifications. Notably, patients with IVa and IVb were not included in the comparison because of the small sample size.

Journal: Neuroimmunomodulation

Article Title: Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features.

doi: 10.1159/000529626

Figure Lengend Snippet: Fig. 5. Comparison of circulating dendritic cell subsets in patients with different MGFA (Myasthenia Gravis Foundation of America) classification as shown, there were no differences in the frequencies of pDCs (a), CD1c+ cDCs (b), and CD141+ cDCs (c) in patients with different MGFA classifications. Notably, patients with IVa and IVb were not included in the comparison because of the small sample size.

Article Snippet: The section was incubated with 10% normal goat serum in phosphate-buffered saline at room temperature, followed by incubation with the primary antibody against CD303 (rabbit antihuman CD303, D161051-0100, Sango Biotech, Shanghai, China), CD1c (mouse anti-human CD1c, TA505384, Zhongshan Jinqiao Biotechnology Co., Ltd, Beijing, China), and CD141 (Rabbit antihuman CD141, BM4158, Boster Biological Technology, Wuhan, China).

Techniques: Comparison